DASH vs VRTX · P/E 76, rev $13.72B vs P/E 30, rev $12.00B
DoorDash, Inc. Class A Common Stock (DASH) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the DASH and VRTX stock pages for the full models.
Not investment advice.